Up a level |
Khalil, Asma, Sharp, AN ORCID: 0000-0003-3396-7464, Cornforth, Christine, Jackson, Richard, Mousa, Hatem, Stock, Sarah, Harrold, J ORCID: 0000-0002-9281-1446, Turner, Mark A ORCID: 0000-0002-5299-8656, Kenny, Louise C ORCID: 0000-0002-9011-759X, Baker, Philip N et al (show 5 more authors)
(2020)
Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early‐onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo‐controlled double‐blind trial.
Ultrasound in Obstetrics and Gynecology, 55 (2).
pp. 198-209.
Sharp, Andrew ORCID: 0000-0003-3396-7464, Cornforth, Christine and Alfirevic, Zarko
(2019)
Learning from the STRIDER trial.
Obstetrics, Gynaecology & Reproductive Medicine, 29 (8).
pp. 240-241.
Sharp, Andrew ORCID: 0000-0003-3396-7464, Cornforth, Christine, Turner, Mark A ORCID: 0000-0002-5299-8656, Harrold, Jane ORCID: 0000-0002-9281-1446, Kenny, Louise C ORCID: 0000-0002-9011-759X, Jackson, Richard, Baker, Philip N, Johnstone, Edward D, Kahlil, Asma, von Dadelszen, Peter et al (show 2 more authors)
(2018)
Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial.
Lancet Child and Adolescent Health, 2 (2).
pp. 93-102.
Sharp, Andrew, Cornforth, Christine, Jackson, Richard, Harrold, Jane ORCID: 0000-0002-9281-1446, Turner, Mark A ORCID: 0000-0002-5299-8656, Kenny, Louise ORCID: 0000-0002-9011-759X, Baker, Philip N, Johnstone, Edward D, Khalil, Asma, von Dadelszen, Peter et al (show 2 more authors)
(2019)
Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction.
LANCET CHILD & ADOLESCENT HEALTH, 3 (3).
E2 - E3.
Sharp, Andrew ORCID: 0000-0003-3396-7464, Cornforth, Christine, Jackson, Richard, Harrold, Jane ORCID: 0000-0002-9281-1446, Turner, Mark A ORCID: 0000-0002-5299-8656, Kenny, Louise ORCID: 0000-0002-9011-759X, Baker, Philip N, Johnstone, Edward D, Khalil, Asma, von Dadelszen, Peter et al (show 2 more authors)
(2019)
Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction.
LANCET CHILD & ADOLESCENT HEALTH, 3 (3).
E2-E3.
Gent, Joanna ORCID: 0000-0001-9969-4871, Bullough, Sian, Harrold, Jane ORCID: 0000-0002-9281-1446, Jackson, Richard, Woolfall, Kerry ORCID: 0000-0002-5726-5304, Andronis, Lazaros, Kenny, Louise ORCID: 0000-0002-9011-759X, Cornforth, Christine, Heazell, Alexander EP, Benbow, Emily et al (show 2 more authors)
(2020)
The PLANES study: a protocol for a randomised controlled feasibility study of the placental growth factor (PlGF) blood test-informed care versus standard care alone for women with a small for gestational age fetus at or after 32+0weeks' gestation.
PILOT AND FEASIBILITY STUDIES, 6 (1).
179-.
Sharp, Andrew ORCID: 0000-0003-3396-7464, Jackson, Richard, Cornforth, Christine, Harrold, Jane ORCID: 0000-0002-9281-1446, Turner, Mark A ORCID: 0000-0002-5299-8656, Kenny, Louise ORCID: 0000-0002-9011-759X, Baker, Philip N, Johnstone, Edward, Khalil, Asma, Von Dadelszen, Peter et al (show 2 more authors)
(2019)
A Prediction Model for Short-Term Neonatal Outcomes in Severe Early-Onset Fetal Growth Restriction.
European Journal of Obstetrics and Gynecology and Reproductive Biology, 241.
pp. 109-118.
Liauw, Jessica, Groom, Katie, Ganzevoort, Wessel, Gluud, Christian, McKinlay, Christopher JD, Sharp, Andrew, Mackay, Laura, Kariya, Chirag, Lim, Ken, von Dadelszen, Peter et al (show 30 more authors)
(2021)
Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis.
Systematic Reviews, 10 (1).
305-.